Eagle Pharmaceuticals, Inc. EGRX
Performance
| Periode | EGRX | COLL | PAHC | ANIP | LIEN | ENTA | XNCR | SUPN |
|---|---|---|---|---|---|---|---|---|
| 6M | 33.33 % | 21.94 % | 112.87 % | 32.52 % | -2.85 % | 137.63 % | 55.21 % | 55.21 % |
| YTD | 280.95 % | 12.02 % | 79.71 % | 62.82 % | -17.16 % | 99.37 % | -44.28 % | 34.93 % |
| 1Y | 166.67 % | -15.61 % | 53.37 % | 54.31 % | -21.35 % | -1.46 % | -36.97 % | 49.31 % |
| 3Y | -94.25 % | 81.08 % | 168.39 % | 167.47 % | 0.53 % | -76.90 % | -52.41 % | 52.94 % |
| 5Y | -96.50 % | 48.20 % | 99.64 % | 211.38 % | -25.68 % | -75.70 % | -68.22 % | 135.07 % |
| 10Y | -97.40 % | 68.43 % | 18.45 % | 136.87 % | -25.68 % | -69.73 % | 13.39 % | 234.61 % |
| From the beginning | -87.53 % | 160.94 % | 119.14 % | -57.77 % | -25.68 % | -35.13 % | 58.93 % | 815.34 % |